Related Experiment Video

Updated: Jul 26, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Signal-averaged ECG in patients with antidepressant therapy

B Mladosievicova1, I Hulin, J Pogady

  • 1Institute of Pathophysiology, School of Medicine, Comenius University, Bratislava, Slovak Republic.

International Journal of Cardiology
|April 19, 1996
PubMed

Insights

Signal-averaged electrocardiography (SAECG) can detect arrhythmia risks. This study shows that sodium channel blocking antidepressants significantly alter SAECG parameters, suggesting SAECG

Area of Science:

  • Cardiology
  • Psychopharmacology
  • Medical Technology

Background:

  • Signal-averaged electrocardiography (SAECG) is used to identify patients at risk of ventricular arrhythmias and sudden cardiac death.
  • Tricyclic antidepressants share pharmacological similarities with class I antiarrhythmics, raising concerns about potential proarrhythmic effects.
  • The influence of sodium channel blocking antidepressants on SAECG parameters requires further investigation.

Purpose of the Study:

  • To evaluate the impact of sodium channel blocking antidepressant drugs on time-domain parameters of SAECG.
  • To assess changes in SAECG variables before and after initiating antidepressant therapy in depressed patients.
  • To explore the potential of SAECG in risk stratification of psychiatric patients undergoing antidepressant treatment.

Main Methods:

  • Signal-averaged electrocardiography (SAECG) was performed on 11 depressed patients with normal cardiac status.
  • SAECG measurements were taken before and after 4 weeks of antidepressant initiation.
  • High-pass filters of 25 Hz and 40 Hz were utilized to analyze SAECG time-domain parameters.

Main Results:

  • Antidepressant therapy significantly worsened SAECG parameters, including prolonged filtered QRS duration and reduced root mean square voltages.
  • Both 25 Hz and 40 Hz high-pass filters revealed similar adverse effects on SAECG variables.
  • Late potentials (LP) were induced by amitriptyline and maprotiline in 2 patients at a 40 Hz filter setting.

Conclusions:

  • Sodium channel blocking antidepressants can significantly affect SAECG variables, mirroring effects seen with class I antiarrhythmics.
  • SAECG may serve as a valuable tool for categorizing antidepressant agents and stratifying cardiac risk in psychiatric patients.
  • This pilot study highlights the importance of monitoring cardiac electrophysiology during antidepressant therapy.

More Related Videos

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Concept Videos

Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...